
Search
Choose your country site and preferred display language.
L0950
Accutase® is a ready-to-use cell detachment solution composed of proteolytic and collagenolytic enzymes. It can replace trypsin/EDTA during cell passages. It can also be used on cells in suspension to reduce their agglutination for counting.
Accutase® has been shown to be effective on a wide range of primary cells and cell lines, such as fibroblasts, keratinocytes, vascular endothelial cells, hepatocytes, vascular smooth muscle cells, bone marrow stem cells, adherent CHO and BHK cells, 293 cells, L929 cells, 3T3 cells, Vero, HeLa.
(Accutase is a registered trademark of Innovative Cell Technologies, Inc.)
Other packagings available on request
State
Frozen
Storage
-18°C to -40°C
Shipping
Gel pack, dry ice or refrigerated transport
Shelf Life
24 months
Sterility
All documents are available as PDF. Safety Data Sheets and Product Specifications are available in multiple languages. Certificate of Analysis documents are issued per production lot.

Technical specifications, quality data, and application details. Only available in English.
Hazard information, handling, storage, and disposal. Other languages available on request.
Latest issues of Biowest’s marketing material. Only available in English.
Product composition details, including formulation components and concentrations. Available as a PDF.
No documents are currently available for this product. Please contact us if you have any questions.
Cell culture
Main advantages of Accutase:
– Less damaging to cells
– Increased cell viability
– Reduced risk of introducing adventitious agents
– Significant reduction of all mammalian or bacterial derived proteins
– Increased efficiency of cell seeding
– Improved cell morphology and proliferation
– Especially useful for cells grown in a serum/protein-free culture environment.
Choose your country site and preferred display language.
Select your country